US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.540
  • +0.160+2.17%
Close Mar 11 16:00 ET
  • 7.540
  • 0.0000.00%
Post 16:05 ET
1.58BMarket Cap-17.53P/E (TTM)

BioCryst Pharmaceuticals Key Stats

BioCryst Pharmaceuticals Q4 2024 Earnings Date

Currency:USDFeb 24, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
130.05M
131.53M
+1.49M
Beat Est.
+39.23%
+40.83%
+1.14%
EPS
-0.05
-0.13
-0.08
Miss Est.
+82.38%
+58.06%
-138.10%
Strong Buy

Mar 11, 2025

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 139.106M--
--2025/Q1-- / 126.700M--
Feb 24, 20252024/Q4131.534M / 130.047M--
Nov 4, 20242024/Q3117.085M / 112.666M--
Aug 5, 20242024/Q2109.332M / 98.324M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 139.106M--
--2025/Q1-- / 126.700M--
Feb 24, 20252024/Q4131.534M / 130.047M--
Nov 4, 20242024/Q3117.085M / 112.666M--
Aug 5, 20242024/Q2109.332M / 98.324M--

Unlock Free Earnings Estimates

BioCryst Pharmaceuticals Earnings Reports

Read more

Trending Stocks

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More